Which dimensions of fatigue should be measured in patients with rheumatoid arthritis? A Delphi study

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)

Abstract

Objective: Rheumatoid arthritis (RA) patients experience fatigue as a multidimensional symptom. The aim of the present study was to use health professionals and patients alike to identify which dimensions of fatigue should be measured in RA. Methods: Twelve fatigue dimensions were constructed, based on items from traditional questionnaires and items generated from interviews. Health professionals and patients evaluated these dimensions, related to an initial pool of 294 items, in a Delphi procedure. Dimensions were selected if rated important by at least 80% of the participants. Results: Ten rheumatologists, 20 nurses and 15 patients participated. All fatigue dimensions were selected directly (severity, frequency, duration, changes in fatigue, perceived causes of fatigue, energy, sleep/rest, body feeling, cognition/concentration, coping, negative emotions/mood and consequences). No additional dimensions emerged from participants' comments and suggestions. Conclusions: This study revealed 12 fatigue dimensions. This underlines the multidimensionality of fatigue in RA and the need for comprehensive measurement.
Original languageEnglish
Pages (from-to)13-17
JournalMusculoskeletal care
Volume10
Issue number1
DOIs
Publication statusPublished - 11 Nov 2012

Fingerprint

Delphi Technique
Fatigue
Rheumatoid Arthritis
Emotions
Health
Cognition
Sleep
Nurses
Interviews

Keywords

  • METIS-289564
  • IR-82287

Cite this

@article{17a5496c00484cf290b611d1ca40a2ba,
title = "Which dimensions of fatigue should be measured in patients with rheumatoid arthritis? A Delphi study",
abstract = "Objective: Rheumatoid arthritis (RA) patients experience fatigue as a multidimensional symptom. The aim of the present study was to use health professionals and patients alike to identify which dimensions of fatigue should be measured in RA. Methods: Twelve fatigue dimensions were constructed, based on items from traditional questionnaires and items generated from interviews. Health professionals and patients evaluated these dimensions, related to an initial pool of 294 items, in a Delphi procedure. Dimensions were selected if rated important by at least 80{\%} of the participants. Results: Ten rheumatologists, 20 nurses and 15 patients participated. All fatigue dimensions were selected directly (severity, frequency, duration, changes in fatigue, perceived causes of fatigue, energy, sleep/rest, body feeling, cognition/concentration, coping, negative emotions/mood and consequences). No additional dimensions emerged from participants' comments and suggestions. Conclusions: This study revealed 12 fatigue dimensions. This underlines the multidimensionality of fatigue in RA and the need for comprehensive measurement.",
keywords = "METIS-289564, IR-82287",
author = "Stephanie Nikolaus and Christina Bode and Erik Taal and {van de Laar}, {Mart A F J}",
year = "2012",
month = "11",
day = "11",
doi = "10.1002/msc.222",
language = "English",
volume = "10",
pages = "13--17",
journal = "Musculoskeletal care",
issn = "1478-2189",
publisher = "Wiley-Blackwell",
number = "1",

}

Which dimensions of fatigue should be measured in patients with rheumatoid arthritis? A Delphi study. / Nikolaus, Stephanie; Bode, Christina; Taal, Erik; van de Laar, Mart A F J.

In: Musculoskeletal care, Vol. 10, No. 1, 11.11.2012, p. 13-17.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Which dimensions of fatigue should be measured in patients with rheumatoid arthritis? A Delphi study

AU - Nikolaus, Stephanie

AU - Bode, Christina

AU - Taal, Erik

AU - van de Laar, Mart A F J

PY - 2012/11/11

Y1 - 2012/11/11

N2 - Objective: Rheumatoid arthritis (RA) patients experience fatigue as a multidimensional symptom. The aim of the present study was to use health professionals and patients alike to identify which dimensions of fatigue should be measured in RA. Methods: Twelve fatigue dimensions were constructed, based on items from traditional questionnaires and items generated from interviews. Health professionals and patients evaluated these dimensions, related to an initial pool of 294 items, in a Delphi procedure. Dimensions were selected if rated important by at least 80% of the participants. Results: Ten rheumatologists, 20 nurses and 15 patients participated. All fatigue dimensions were selected directly (severity, frequency, duration, changes in fatigue, perceived causes of fatigue, energy, sleep/rest, body feeling, cognition/concentration, coping, negative emotions/mood and consequences). No additional dimensions emerged from participants' comments and suggestions. Conclusions: This study revealed 12 fatigue dimensions. This underlines the multidimensionality of fatigue in RA and the need for comprehensive measurement.

AB - Objective: Rheumatoid arthritis (RA) patients experience fatigue as a multidimensional symptom. The aim of the present study was to use health professionals and patients alike to identify which dimensions of fatigue should be measured in RA. Methods: Twelve fatigue dimensions were constructed, based on items from traditional questionnaires and items generated from interviews. Health professionals and patients evaluated these dimensions, related to an initial pool of 294 items, in a Delphi procedure. Dimensions were selected if rated important by at least 80% of the participants. Results: Ten rheumatologists, 20 nurses and 15 patients participated. All fatigue dimensions were selected directly (severity, frequency, duration, changes in fatigue, perceived causes of fatigue, energy, sleep/rest, body feeling, cognition/concentration, coping, negative emotions/mood and consequences). No additional dimensions emerged from participants' comments and suggestions. Conclusions: This study revealed 12 fatigue dimensions. This underlines the multidimensionality of fatigue in RA and the need for comprehensive measurement.

KW - METIS-289564

KW - IR-82287

U2 - 10.1002/msc.222

DO - 10.1002/msc.222

M3 - Article

VL - 10

SP - 13

EP - 17

JO - Musculoskeletal care

JF - Musculoskeletal care

SN - 1478-2189

IS - 1

ER -